v3 Template
V

Viridian Therapeutics, Inc.

Biotechnology/Healthcare Waltham, Massachusetts ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$1.1B
Funding Rounds
5
Last Funding
2025-10-21

About Viridian Therapeutics, Inc.

Viridian Therapeutics is focused on framing the future of autoimmune diseases by leveraging expertise in antibody discovery and engineering to develop optimized treatments for rare autoimmune conditions, with a particular emphasis on improving patient care through innovative therapeutics.

Products & Services

Thyroid Eye Disease (TED) Programs:Programs dedicated to addressing Thyroid Eye Disease, a rare autoimmune condition.
FcRn Portfolio:A portfolio of treatments targeting FcRn, aimed at autoimmune disease management.

Specialties

Antibody Discovery Antibody Engineering Rare Autoimmune Conditions Thyroid Eye Disease (TED)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 251000000
MR: -
FA: $251 million
FAN: 251000000
D: 2025-10-21
FD: 2025-10-21
5 investors
2 RT: Royalty Financing
T: -
FT: Royalty Financing
A: 300000000
MR: -
FA: up to $300 million
FAN: 300000000
D: 2025-10-20
FD: 2025-10-20
2 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 225000000
MR: -
FA: $225.0 million
FAN: 225000000
D: 2024-09-11
FD: 2024-09-11
5 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 150000000
MR: -
FA: $150 million
FAN: 150000000
D: 2024-09-10
FD: 2024-09-10
5 investors
5 RT: Public Offering
T: -
FT: Public Offering
A: 150000000
MR: -
FA: approximately $150.0 million
FAN: 150000000
D: 2024-01-17
FD: 2024-01-17
2 investors
Public Offering Latest
2025-10-21
$251.0M
5 investors (Pro only)
Royalty Financing 2025-10-20
$300.0M
Public Offering 2024-09-11
$225.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Steve Mahoney

President and CEO

T

Tom Beetham

Chief Operating Officer

S

Shan Wu

Chief Business Officer

R

Radhika Tripuraneni

Chief Medical Officer

T

Tony Casciano

Chief Commercial Officer

M

Melissa Manno

Chief Human Resources Officer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Viridian Therapeutics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~360 employees (est.)
Locations
Waltham, Massachusetts

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro